- Guaranteed increase in already-high number of patient referrals;
- Strengthened patient retention rate through Remedy's HIPAA-compliant, proprietary mobile content and adherence tools; and
- Exclusive media placement capabilities.
These stocks boast both growing dividend income and promising technical charts.
The Starcom Mediavest and Leo Burnett owner says restructuring benefits should kick in from 2017, and it sees little impact from Brexit.